CEOInterviews.AI
Start App
Get an email when Robert Langer gives a new interview
One email per new interview. Unsubscribe in one click.
Robert Langer
Institute Professor, MIT

Founder, Moderna (Grew to $190B) & Most Cited Engineer in History: MIT Professor Robert S. Langer

📅 Aug 12, 2026 Cutting to the Case 15 MIN 320 VIEWS 37 SEGMENTS · 2 SPEAKERS
Dr. Robert Langer is one of the most influential biomedical inventors in history. An Institute Professor at MIT, he has helped pioneer technologies spanning drug delivery, tissue engineering, biotechnology, and mRNA therapeutics, and was a co-founder of Moderna. In this episode of Cutting to the Case, Dr. Langer joins Cameron Sabet to discuss how transformative medical technologies go from ideas in a laboratory to companies capable of changing millions of lives, what he has learned from building biotechnology companies, and the principles that have guided one of the most consequential careers...

What Robert Langer said

Written from the verified transcript and checked against it. Every figure links to the moment it was said.

Robert Langer, Institute Professor at MIT, discussed the biggest opportunities in medicine, emphasizing basic science and technologies like gene editing, messenger RNA, and cellular therapies. He stressed that turning discoveries into companies requires a team effort, and that successful entrepreneurs never give up and dream big. He cited Moderna as an example of teamwork, mentioning key people like Stéphane Bancel and Nubar Beyen. Langer highlighted the importance of targeting drugs to specific cells, and his lab's work with the Gates Foundation on vaccines and nutrition for the developing world. He defended animal testing for safety, and said the media should communicate the positives of research. He wants to be remembered for his polymer and lipid delivery systems, which he says have been used by over a billion people. His advice to early career researchers is to dream big and almost never give up.

Key takeaways

  1. Langer said his polymer and lipid delivery systems have been used by over a billion people, possibly many billions.
  2. He cited Moderna as a team effort, naming CEO Stéphane Bancel and chairman Nubar Beyen as key contributors.
  3. He defended animal testing, saying the FDA requires it and it ensures safety.
  4. He said his lab works with the Gates Foundation on self-boosting vaccines and long-lasting pills for the developing world.

Numbers and commitments

FigureWhat it refers toTypeAt
14, 15 years ago time before CRISPR became important timeline 1:11
1,600 papers papers authored by Langer metric 0:02
1,500 patents patents issued or pending metric 0:02
400 companies companies licensed his technologies metric 0:02

Chapters

  1. 0:00Biggest opportunities in medicine
  2. 2:49Turning discoveries into companies
  3. 3:41Qualities of world-changers
  4. 4:14Distinguishing ahead vs. wrong
  5. 5:00Building companies for nonexistent markets
  6. 6:08Moderna as a team effort
  7. 7:16Basic science and technology needs
  8. 8:26Developing world vaccines and nutrition
  9. 9:37Polymer targeting and delivery
  10. 10:34Convincing public of basic science

Questions asked in this interview

12
  1. 0:58When you're looking at medicine today, where do you see the biggest opportunities that we're all still missing?
  2. 2:34What have you learned about turning a scientific discovery into a company that actually succeeds?
  3. 3:29What separates, in your mind, the ones who actually change the world from the people who are merely extremely intelligent?
  4. 4:02How do you tell the difference between being ahead of everyone else and simply being wrong?
  5. 4:52And how do you build a company around a technology when the market for that technology doesn't really exist yet?
  6. 5:55And when you think about, you know, Moderna, for instance, what did the creation of Moderna teach you about building a company around a technology that still had enormous scientific uncertainty?
  7. 7:03When you look at medicine today, where do you see the biggest opportunities that we're still missing?
  8. 8:10Could you maybe expound on the number one problem in your head right now, scientifically?
  9. 9:17What are the best kind of shining examples that you can think of outside of just, outside of vaccines in the developing world that really excite you about polymers as well?
  10. 10:01How do you convince people outside of the scientific community that, for instance, murine models are worth pursuing, or places that are further away from clinical or applicable research?
  11. 12:05And after everything you've accomplished, if your career had to be remembered for one idea rather than all the awards, companies, papers, patents, what would you want that idea to be?
  12. 13:14So, I'm curious if you had advice for the audience of the show, which is primarily early career researchers and medical students and early career business leaders as well, what would you have to say to them?
Cameron Sabbat 0:02 ↗
Hello, this is Cameron Sabbat with Cutting to the Case, and today we're joined by Dr. Robert Langer. He's an Institute Professor at MIT, the university's highest faculty distinction, held by only a handful of professors, and one of the most influential biomedical inventors in history. He pioneered controlled drug delivery and helped lay the foundations of tissue engineering, and has authored more than 1,600 papers and holds more than 1,500 issued or pending patents. His technologies have been licensed to more than 400 companies, and he's helped found dozens of biotechnology companies, including Moderna.
He's also trained hundreds of scientists and entrepreneurs, creating what has become known as the Langer Tree, a network of former trainees who have gone on to found companies and lead laboratories around the world. His honors include both the U.S. National Medal of Science and National Medal of Technology and Innovation, the Queen Elizabeth Prize for Engineering, the Breakthrough Prize, Kyoto Prize, and Millennium Technology Prize. Dr. Langer, thank you so much for joining us today.
Robert Langer 0:57 ↗
Thank you.
Cameron Sabbat 0:58 ↗
Thank you. So, I'm curious. We only have a little bit of time here. When you're looking at medicine today, where do you see the biggest opportunities that we're all still missing?
Robert Langer 1:11 ↗
Well, I always think it's what hasn't been doesn't have a name because it hasn't been discovered yet. You know, it's interesting. I mean, if you look at gene editing and CRISPR, which is the way that a lot of people edit genes, you know, if you asked somebody about that question, you know, about 14, 15 years ago, and you know, they would have said, well, CRISPR, that has to do with cooking, you know. But now, of course, it's become very, very important as a way of inserting genes, and that certainly is one of the big areas for today. But I think what's great about basic research is that sometimes people will discover things intentionally or unintentionally that can change the world and can change the future of medicine. And so I think that there are things that we don't know yet.
Now, the areas that we do know and certainly will people will continue to make advances are genetic therapies like gene editing, messenger RNA, you know, ways of turning genes on and off. And then I also think cellular therapies, whether they be engineered cells to treat cancer like CAR T cells or regenerative medicine approaches, you know, which can affect longevity and make new tissues and organs, and even organs and tissues on a chip. So there's a lot, a lot of things that are going on that are very exciting.
Cameron Sabbat 2:34 ↗
Absolutely. And you know, from all of these insights that you've had, you've helped build dozens of biotechnology companies. What have you learned about turning a scientific discovery into a company that actually succeeds?
Robert Langer 2:49 ↗
It's a team effort. You know, it's one thing to discover something and make an invention. It's very, very different to really get it out to the world. And it takes a real team. It takes great scientists, but it also takes great business people, great investors, people that can do manufacturing, people that are clinicians, and that team has to work together. And it's a struggle. It's very, very hard because there's many challenges. Anything along the way can stop you. And certainly medicine is not, you know, medical research is not cheap. So, but it's incredibly important because it, you know, it saves, you know, billions of lives.
Cameron Sabbat 3:29 ↗
And speaking of teamwork, you've met and trained thousands of brilliant people. What separates, in your mind, the ones who actually change the world from the people who are merely extremely intelligent?
Robert Langer 3:41 ↗
Well, I think it's never giving up. I think it's laser kind of focus. It's being willing to walk through walls when there, you know, are issues. And it's, you know, really a passion, you know, to really want to do something that'll make a giant difference.
Cameron Sabbat 4:02 ↗
And, you know, there's passion and there's walking through walls, but you've had ideas that experts initially thought were impossible. How do you tell the difference between being ahead of everyone else and simply being wrong?
Robert Langer 4:14 ↗
Yeah. Well, that's a challenge. You know, sometimes it's a judgment call. And you know, it also depends on what data you really have, whether somebody is telling you you're wrong because they're jealous or opinionated, or whether they really have good evidence that you're wrong. You know, and I think it's important. When people told me I was wrong, I always listened. But I, sorry, not to. But you know, I think that I had certainly seen the data that we had, and it certainly made sense to me, and I felt it was theoretically possible regardless of what people said.
Cameron Sabbat 4:52 ↗
And how do you build a company around a technology when the market for that technology doesn't really exist yet?
Robert Langer 5:00 ↗
Well, so the question is how do you build a company around a technology when the market for that technology doesn't really exist yet?
Yeah. Well, that's a very good question. You know, there was a guy, was it Clayton Christensen, who wrote, you know, called The Innovator's Dilemma. He wrote a book called that. And that's, but his point was that that was what you wanted to do was a lot of times the things that have been most successful, the market didn't exist. But you created that market because of that discovery. And so I think, how do you do it? I think it's like you realize, even if other people don't, that maybe what you've done to create opportunities that never existed before, but they couldn't exist because that discovery or invention hadn't been made. And then you think through how that can make the biggest difference now.
Cameron Sabbat 5:55 ↗
Yeah. Yes. And when you think about, you know, Moderna, for instance, what did the creation of Moderna teach you about building a company around a technology that still had enormous scientific uncertainty?
Robert Langer 6:08 ↗
Yeah. Well, Moderna, you know, that again is a great example of a team effort. You know, we had a great CEO, Stéphane Bancel, chairman Nubar Beyen, you know, who was an investor in it as well, and just great scientists. You know, Melissa Moore, Stephen Hoge, you know, Carrie Brodard, we had lots of just great people. A lot of my students, you know, I think it just, and people worked around the clock, you know, when the COVID thing happened, they were working round the clock because they felt that they could make a giant difference. And I think that, you know, that people felt that we all felt that we were doing something very, very important. And I think when you're doing something, you feel that the research you're doing is very important, then people band together and they solve problems.
Cameron Sabbat 7:03 ↗
Yes. And it all really comes back to teamwork, and teamwork helps you spot those opportunities. When you look at medicine today, where do you see the biggest opportunities that we're still missing?
Robert Langer 7:16 ↗
Well, I think a lot of it really comes down to basic science and understanding things better. You know, I don't think we understand. I mean, there's certainly a lot we don't know about cancer, you know, about why a cell becomes cancerous and how you can control that whole thing. There's a lot we don't know about the brain, and if we could, that might teach us how to stop diseases like Alzheimer's and others. So I think a lot does come down to the basic biology about what causes the abnormalities that we have. And so I think a lot of it's basic science, and then the rest of it is technologies. I mean, you know, technologies can make a giant difference. You know, better delivery systems, better imaging techniques, you know, all kinds of things like that, ways to target drugs to specific cells in the body.

17 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Langer, R. (2026, August 12). Founder, Moderna (Grew to $190B) & Most Cited Engineer in History: MIT Professor Robert S. Langer [Interview transcript]. Cutting to the Case. CEOInterviews.AI. https://ceointerviews.ai/interview/3122452/

MLA

Robert Langer. "Founder, Moderna (Grew to $190B) & Most Cited Engineer in History: MIT Professor Robert S. Langer." Cutting to the Case, 12 Aug. 2026. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3122452/.

BibTeX
@misc{langer2026_3122452,
  author       = {Robert Langer},
  title        = {Founder, Moderna (Grew to $190B) \& Most Cited Engineer in History: MIT Professor Robert S. Langer},
  howpublished = {Interview transcript, Cutting to the Case. CEOInterviews.AI},
  year         = {2026},
  month        = {aug},
  url          = {https://ceointerviews.ai/interview/3122452/},
  note         = {Speaker-attributed transcript with timestamps}
}